04:34 PM EDT, 10/03/2024 (MT Newswires) -- William Guyer, Chief Development Officer, on October 01, 2024, sold 10,000 shares in Corcept Therapeutics ( CORT ) for $462,800. Following the Form 4 filing with the SEC, Guyer has control over a total of 5,796 shares of the company, with 5,796 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017024112385/xslF345X05/ownership.xml